Skip to content
Nonprofiteer
← STAAR OVARIAN CANCER

Form 990 for tax year 2024

Filed by STAAR OVARIAN CANCER.

Totals

Total revenue
$299,828
Total expenses
$56,165
Contributions and grants received
$289,414
Grants paid
$0
Program service revenue
$10,050
Investment income
$364
Other revenue
$0
Total assets, end of year
$464,353
Total liabilities, end of year
$71,842
Net assets or fund balances, end of year
$392,511
Program services expenses (Part IX)
$56,165
Management and general expenses
$0
Fundraising expenses
$0
Program service expenses (Part III)
$56,165

Program services were 100.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $289,414

  • 2a · Program service revenue: SPECIAL EVENT

    total $7,050 · related or exempt $7,050

  • 2b · Program service revenue: ELPFDD MEETING INCOME

    total $3,000 · related or exempt $3,000

  • 3 · Investment income

    total $364 · related or exempt $364

Functional expenses

Part IX, the statement of functional expenses.

  • 11c · Fees: accounting

    total $3,338 · program services $3,338

  • 11g · Fees: other

    total $8,650 · program services $8,650

  • 12 · Advertising and promotion

    total $324 · program services $324

  • 13 · Office expenses

    total $2,062 · program services $2,062

  • 14 · Information technology

    total $5,779 · program services $5,779

  • 16 · Occupancy

    total $1,022 · program services $1,022

  • 24a · Other expenses: AWARENESS MATERIALS

    total $34,990 · program services $34,990

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $448,000 · end of year $436,863

  • 3 · Pledges and grants receivable

    end of year $27,490

  • 17 · Accounts payable and accrued expenses

    beginning of year $299,152 · end of year $37,795

  • 19 · Deferred revenue

    end of year $34,047

  • 27 · Net assets without donor restrictions

    beginning of year $148,848 · end of year $392,511

Mission and programs · 2024

Mission

STAAR EXISTS TO ADVOCATE FOR AND RAISE FUNDS FOR RESEARCH SPECIFICALLY ON THE LOW-GRADE SEROUS CARCINOMA SUB-TYPE OF OVARIAN CANCER IN THE UNTED STATES. THROUGHOUT THE YEAR, WE DROVE AWARENESS OF THE SYMPTOMS OF OVARIAN CANCER AND THE UNDER-FUNDING OF RESEARCH FOR THE LGSC SUB-TYPE. WE MAKE CONNECTIONS WITH RESEARCHERS AND ULTIMATELY HAVE MADE THREE GRANTS, SOOME WITH FUNDS RAISED IN 2021.

Activities or mission (Part I)

STAAR EXISTS TO ADVOCATE FOR AND RAISE FUNDS FOR RESEARCH SPECIFICALLY ON THE LOW-GRADE SEROUS CARCINOMA SUB-TYPLE OF OVARIAN CANCER IN THE UNITED STATES. WE DRIVE AWARENESS OF THE SYMPTOBS OF OVARIAN CANCER AND THE UNDER-FUNDING OF RESEARCH FOR THE LGSC SUB-TYPE. WE STRENGTHEN OUR CONNECTIONS WITH RESEARCHERS TO UNDERSTAND RESEARCH NEEDS, FUNDING NEEDS, AND HISTORICALLY RAISED ENOUGH FUNDS THROUGH DONATIONS TO GIVE THREE RESEARCH GRANTS FOR LGSOC. ONE OF THE FUNDED STUDIES WAS FUNDED WITH MONEY DONATED IN 2021.

  • CONTINUING SUPPORTING AND EXPANDING AN AWARENESS CAMPAIGN OF LGSOC.

    Expenses $47,515 · Revenue $7,050

  • AWARDED RESEARCH GRANTS FOR LGSOC

  • CREATED AND CONDUCTED A SURVERY OF LGSOC PATIENTS PERPECTIVES ON TREATMENTS AND DOCTOR INTERACTIONS WHICH ARE PRESENTED AT LGSOC RESEARCH CONFERENCE. PLAN, SUPPORT, AND HOLD AN EXTERNALLY-LED PATIENT FOCUSED DRUG DEVELOPMENT MEETING AS DIRECTED BY THE US FDA FOR PATIENTS TO PRESENT THEIR PERSPECTIVES ON LIVING WITH THEIR RARE DISEASE AND THEIR DAILY LIFE WITH THE CURRENT TREATMENTS. PROVIDE A PLATFORM FOR PATIENTS TO SHARE THEIR THOUGHTS ON DRUG DEVELOPMENT AND SIDE EFFECTS.

    Expenses $8,650 · Revenue $3,000

  • ANY OTHER MARKETING RESEARCH SUPPORT SERVICES THAT BENEFITS AWARENESS OF LGSC SUB-TYPE.

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Connie Bell

    DIRECTOR

    Total calculated
    $0
    Hours/week
    8

  • Mark Blake

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2

  • Ellie Habib

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Tiffany Locke

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Bailey Wolfe

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Nicole Andrews

    CHAIR

    Total calculated
    $0
    Hours/week
    9

  • Christina Campbell

    TREASURER

    Total calculated
    $0
    Hours/week
    3

  • Morgan Gaynor

    SECRETARY

    Total calculated
    $0
    Hours/week
    3

  • Kari Neumeyer

    V-CHAIR MARK

    Total calculated
    $0
    Hours/week
    10

  • Emma Schlamm

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2

  • Alyssa Toomes

    V-CHAIR FUND

    Total calculated
    $0
    Hours/week
    3

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

No itemized grants to organizations on this return.

Provenance

Return type
form_990
Tax year
2024
Filed
13 November 2025
IRS schema version
2024v5.0
Source object
202543209349301659

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.